{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T23:08:01Z","timestamp":1744153681105},"reference-count":23,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"published-print":{"date-parts":[[1989,8]]},"abstract":"<jats:p>24 cases of fulminant hepatitis (FH) hospitalized in the Cl\u00ednica de Doen\u00e7as Infecciosas e Parasit\u00e1rias do Hospital das Cl\u00ednicas da Faculdade de Medicina da Universidade de S\u00e3o Paulo during the period from January 1976 to December 1986 were reviewed from their clinical, epidemiological and laboratorial aspects. 88% of the patients died; 20 patients (83%) presented hemorrhages and, of these, 19 died. Bacterial infections occurred in 14 patients (58%) all of whom died. Ascitis was noted in 3 cases; cerebral edema was present in 16 cases. Maximal ALT levels for each patient during hospitalization ranged widely from 81 to 4,460 UI\/l. Thirteen patients presented high creatinine levels (54%). Prothrombin time activity ranged from 2.1% to 67%. Fever was present in 20 cases (83%). Encephalopathy occurred within the first 2 weeks of illness in 72% of the cases. In 7 cases other illnesses were present. The etiology could not be determined in 13 cases. In 3 cases it was due to yellow fever and 6 cases were caused by viruses other than yellow fever. In one case the cause was drug usage and in another case, possibly alcohol. The authors believe that the clinical definition of FH requires further discussion before it is established. In this study FH is a young person's disease. The mortality found was similar to that by other authors. Factors that contributed to death were: hemorrhages and bacterial infection. Factors that worsened the prognosis of hepatitis were: associated illnesses and surgical procedure. The levels of ALT during hospitalization did not correlate well with the severity of the hepatitis. The authors believe that yellow fever should be considered a cause of FH where the clinical picture meets the criteria for such, although its mechanisms of encephalopathy remain obscure. The clinical details of the 3 cases of yellow fever are presented.<\/jats:p>","DOI":"10.1590\/s0036-46651989000400002","type":"journal-article","created":{"date-parts":[[2017,2,4]],"date-time":"2017-02-04T09:51:58Z","timestamp":1486201918000},"page":"213-220","source":"Crossref","is-referenced-by-count":2,"title":["Fulminant hepatitis: a clinical review of 11 years"],"prefix":"10.1590","volume":"31","author":[{"given":"Anna Sara Shafferman","family":"Levin","sequence":"first","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Alci","family":"Barone","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Shiroma","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bmj.292.6517.376","article-title":"Lack of correlation between fulminant form of viral hepatitis and retrovirus infection associated with the acquired immune deficiency syndrome (AIDS) in drug addicts","volume":"292","author":"AMOROSO P.","year":"1986","journal-title":"Brit. med. J.","ISSN":"http:\/\/id.crossref.org\/issn\/0267-0623","issn-type":"print"},{"issue":"70","key":"ref2","first-page":"76","article-title":"Fulminant hepatitis B among parenteral drug abusers Kentucky, California","volume":"33","year":"1984","journal-title":"M.M.W.R."},{"key":"ref3","first-page":"687","article-title":"Hepatitis aguda fulminante: Revision de 53 casos de presunta etiologia v\u00edrica","volume":"52","author":"DOMINGUEZ F.M.","year":"1978","journal-title":"Rev. esp. Enferm. Apar. dig."},{"key":"ref4","first-page":"124","article-title":"Current concepts in viral hepatitis","volume":"16","author":"HOOFNAGLE J.H.","year":"1979","journal-title":"Arch. Gastroent. (S. Paulo)"},{"key":"ref5","series-title":"Diseases of the liver","first-page":"525","volume-title":"Viral hepatitis","author":"KOFF R.S.","year":"1982"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/gut.21.11.962","article-title":"Portal hypertension in fulminant viral hepatitis","volume":"21","author":"LEBREC D.","year":"1980","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref7","first-page":"179","article-title":"Hepatite fulminante por v\u00edrus: Aspectos de etiologia e fisiopatologia","volume":"42","author":"LEVIN A.S.S.","year":"1987","journal-title":"Rev. Hosp. Clin. Fac. Med. S. Paulo"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/00034983.1982.11687519","article-title":"Fulminant virus hepatitis in late pregnancy","volume":"76","author":"MALLIA CP.","year":"1982","journal-title":"Ann. trop. Med. Parasit.","ISSN":"http:\/\/id.crossref.org\/issn\/0003-4983","issn-type":"print"},{"key":"ref9","first-page":"508","article-title":"Complications of viral hepatitis: International Symposium on Viral Hepatitis, 1971","volume":"106","author":"MARTINI G.A.","year":"1972","journal-title":"Canad. med. Ass. J."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/gut.21.1.72","article-title":"Hepatitis type A, B and nonA-nonB in fulminant hepatitis","volume":"21","author":"MATHIESEN L.R.","year":"1980","journal-title":"Gut","ISSN":"http:\/\/id.crossref.org\/issn\/0017-5749","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.5694\/j.1326-5377.1984.tb113175.x","article-title":"Aetiology of fatal viral hepatitis in Melbourne: a retrospective study","volume":"141","author":"McNEIL M.","year":"1984","journal-title":"Med. J. Aust.","ISSN":"http:\/\/id.crossref.org\/issn\/0025-729X","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/9.1.165","article-title":"Yellow fever: a medically neglected disease. Report on a Seminar","volume":"9","author":"MONATH T.P.","year":"1987","journal-title":"Rev. infect. Dis.","ISSN":"http:\/\/id.crossref.org\/issn\/0162-0886","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00000441-197507000-00004","article-title":"Viral hepatitis: a pathologic spectrum","volume":"270","author":"PETERS R.L.","year":"1975","journal-title":"Amer. J. med. Sci."},{"key":"ref14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(75)90694-7","article-title":"Fulminant viral hepatitis","volume":"2","author":"PIAZZA M.","year":"1975","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1136\/bmj.284.6333.1913","article-title":"Acute B viral hepatitis becomes fulminant after infection with hepatitis A virus","volume":"284","author":"PIAZZA M.","year":"1982","journal-title":"Brit, med. J."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0025-6196(12)60534-5","article-title":"Fulminant hepatitis","volume":"60","author":"RAKELA J.","year":"1985","journal-title":"Mayo Clin. Proc."},{"key":"ref17","series-title":"Hepatites agudas e cr\u00f4nicas","first-page":"103","volume-title":"Hepatite fulminante","author":"SETTE JR. H.","year":"1986"},{"key":"ref18","series-title":"Diseases of the liver and biliary system","first-page":"108","volume-title":"Acute (Fulminant) hepatic failure","author":"SHERLOCK S.","year":"1985"},{"key":"ref19","first-page":"1075","article-title":"Hepatite virale fulminant","volume":"103","author":"STAMENKOVIC I.","year":"1983","journal-title":"Rev. m\u00e9d. Suisse rom."},{"key":"ref20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(83)92051-2","article-title":"Does delta agent contribute to fulminant hepatitis?","volume":"1","author":"TABOR E.","year":"1983","journal-title":"Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref21","first-page":"525","article-title":"The fulminant hepatic failure surveillance study: Brief review of the effects of presumed etiology and age of survival. International Symposium on Viral Hepatitis, 1971","volume":"106","author":"TREY C.","year":"1972","journal-title":"Canad. med. Ass. J."},{"key":"ref22","first-page":"59","article-title":"Hepatite fulminant a virus B survenue au cours d'un traitment immuni-d\u00e9presseur","volume":"4","author":"TRINCHET J.C.","year":"1980","journal-title":"Gastroent. clin. biol."},{"key":"ref23","first-page":"29","article-title":"Hepatitis fulminante","volume":"36","author":"VELARDE M.A.P.L.","year":"1976","journal-title":"Rev. Invest. Salud publ. (Mex.)"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v31n4\/02.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T20:07:35Z","timestamp":1601582855000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46651989000400002&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,8]]}},"alternative-id":["S0036-46651989000400002"],"URL":"https:\/\/doi.org\/10.1590\/s0036-46651989000400002","relation":{},"ISSN":["0036-4665"],"issn-type":[{"value":"0036-4665","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8]]}}}